Clinical Trials Directory

Trials / Unknown

UnknownNCT05263531

Remote Ischemic Conditioning for Motor Recovery After Acute Ischemic Stroke

The Safety and Efficacy of Remote Ischemic Conditioning on Motor Recovery After Acute Stroke

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Ji Xunming,MD,PhD · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The most recent treatment for stroke rehabilitation is to combine physical training with other therapies to enhance or accelerate recovery.The hypothesis of this study is that remote ischemic conditioning (RIC) might have a beneficial effect on motor recovery of AIS

Detailed description

Despite the effective reperfusion therapies ,acute ischemic stroke(AIS) is still one of the leading causes of disability, resulting in an economic burden. Multidisciplinary rehabilitation has benefit effects on motor recovery and remains the first-line intervention strategy for attenuating motor function impairments. However, the effect of the physiotherapy application alone is not satisfactory, The potential treatment effect of RIC on motor recovery of AIS has not been investigated. The investigators designed this randomized clinical trial to examine whether RIC has a beneficial effect on poststroke motor function recovery.There are 2 arms in this trial: One arm is RIC treatment, the other one is sham RIC treatment. The motor function will be assessed by Fugl-Meyer Motor Scale before and after the treatment to evaluate its exact effect on motor recovery.

Conditions

Interventions

TypeNameDescription
DEVICEremote ischemic conditioningRIC is a physical strategy performed by an electric autocontrol device with cuffs placed on bilateral arms and inflated to design pressure for 5-min followed by deflation for 5-min, the procedures is performed repeatedly for 5 times.

Timeline

Start date
2021-12-31
Primary completion
2022-12-31
Completion
2023-01-31
First posted
2022-03-02
Last updated
2022-03-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05263531. Inclusion in this directory is not an endorsement.